Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B (Daniel McCoy/Wichita Business Journal)

1 Like Comment
bostonbased valo health seriesmccoy

Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B  —  A Boston-based company working to improve the way drugs are brought to the market has secured $110 million in Series B funding from Koch Disruptive Technologies.

Source

You might like

Avatar

About the Author: uzair

Leave a Reply

Your email address will not be published. Required fields are marked *